HGF-modified UCMSCs (HGF-UCMSCs) have been used in the treatment of bronchiolitis obliterans, wound healing, acute kidney injury, and liver fibrosis, among others (Chen et al., 2011; Li et al., 2015; Cao et al., 2016; Yin et al., 2020). Here, HGF is linked to acute kidney injury.